Impact News +++ RTL werden weniger eigene Aktien angedient als geplant (Dow Jones) +++ RTL Aktie +6,36%

VICORE PHARMA Aktie

>VICORE PHARMA Aktienkurs

0.986 EUR -2.8% (Tradegate)

Ask: 1.024 EUR / 2500 Stück

Bid: 1.002 EUR / 2500 Stück

Tagesumsatz: 1745 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>VICORE PHARMA Performance

1 Woche: -8,1%

1 Monat: -4,7%

3 Monate: +25,3%

6 Monate: +53,3%

1 Jahr: +56,5%

laufendes Jahr: +40,7%

>VICORE PHARMA Aktie

Name:

VICORE PHARMA HOLDING AB

Land:

Schweden

Sektor:

Gesundheit

ISIN/ Wkn:

SE0007577895 / A14W4W

Symbol/ Ticker:

6Y4 (Frankfurt)

Kürzel:

FRA:6Y4, ETR:6Y4, 6Y4:GR

Index:

Webseite:

https://vicorepharma.com/

Profil:

Vicore Pharma Holding AB is a Sweden-based pharmac..
>Volltext..

Marktkapitalisierung:

237.05 Mio. EUR

Unternehmenswert:

153.37 Mio. EUR

Umsatz:

0.69 Mio. EUR

EBITDA:

-32 Mio. EUR

Nettogewinn:

-33.26 Mio. EUR

Gewinn je Aktie:

-0.17 EUR

Schulden:

Liquide Mittel:

31.52 Mio. EUR

Operativer Cashflow:

-29.68 Mio. EUR

Bargeldquote:

14.1

Umsatzwachstum:

-92.44%

Gewinnwachstum:

-88.87%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

VICORE PHARMA

Letzte Datenerhebung:

15.09.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 234.61 Mio. St.

Frei handelbar: 78.88%

Leerverk. Aktien: -

Rückkaufquote: -31.55%

Mitarbeiter: 29

Umsatz/Mitarb.: 0.29 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 252.55%

Bewertung:

KGV: -

KGV lG: -

KUV: 368.17

KBV: 3

PEG-Ratio: -0.83

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -4791.64%

Operative Marge: -4618.46%

Managementeffizenz:

Gesamtkaprendite: -50.98%

Eigenkaprendite: -55.23%

>Peer Group

Es sind 150 Aktien bekannt.

>VICORE PHARMA Chart & Kurs - Tradegate

>VICORE PHARMA News

15.09.25 - 08:30	Vicore Pharma Holding: Vicore to Present at Pareto Securities′ 16th Annual Healthcare Conference (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / September 15, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), toda......

28.08.25 - 08:30	Vicore Pharma Holding: Vicore to Present at Upcoming Investor Conferences (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / August 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today a......

22.08.25 - 08:30	Vicore Pharma Holding: Interim Report April - June 2025 (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / August 22, 2025 / Vicore Pharma Holding AB (STO: VICO) ("Vicore"), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRA......

30.06.25 - 09:30	Vicore Pharma Holding: Increase in Number of Shares and Votes in Vicore Pharma (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor ag......

28.05.25 - 08:31	Vicore Pharma Holding: Vicore to Present at the Jefferies Global Healthcare Conference (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / May 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today anno......

22.05.25 - 09:30	Vicore Pharma Holding: Vicore Presents New Data at the 2025 American Thoracic Society International Conference (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / May 22, 2025 / Vicore Pharma Holding (STO:VICO) - Stockholm, May 22, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs,......

06.05.25 - 16:42	Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding (STO:VICO) - The following resolutions were passed at the annual general meeting (the "AGM") of Vicore Pharma Holding AB (publ)......

06.05.25 - 08:30	Vicore Pharma Holding: Interim Report January - March 2025 (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (A......

02.05.25 - 08:30	Vicore Pharma Holding: Vicore to Present at the Nordea Equities Healthcare Seminar (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / May 2, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today annou......

23.04.25 - 08:18	Vicore Pharma Holding: Vicore Announces Presentations at the 2025 American Thoracic Society International Conference (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / April 23, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drug......

28.03.25 - 08:18	Vicore Pharma Holding: Vicore to Participate in the Van Lanschot Kempen Life Sciences Conference (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / March 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today an......

26.03.25 - 09:06	Notice of Annual General Meeting of Vicore Pharma Holding AB (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO)The shareholders of Vicore Pharma Holding AB (publ), Reg. No. 556680-3804 ("Vicore Pharma" or the "company"), with......

26.03.25 - 08:30	Vicore Pharma Holding: Vicore Publishes the Annual Report for 2024 (Accesswire)
	STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, March 26, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drug......

27.02.25 - 08:42	Vicore Pharma Holding Year-End Report 2024 (Accesswire)
	STOCKHOLM, SWEDEN / ACCESS Newswire / February 27, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, February 27, 2025 - Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of ......

26.02.25 - 08:36	Vicore Pharma Holding: Vicore to Present at Upcoming Investor Conferences (Accesswire)
	STOCKHOLM, SWEDEN / ACCESS Newswire / February 26, 2025 / Vicore Pharma Holding (STO:VICO) Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II typ......

16.09.24 - 23:51	XFRA : CAPITAL ADJUSTMENT INFORMATION - 17.09.2024 - SE0007577895 (XETRA)
	Das Instrument 6Y4 SE0007577895 VICORE PHARMA HOLDING AB EQUITY wird ex Kapitalmassnahme gehandelt am 17.09.2024 The instrument 6Y4 SE0007577895 VICORE PHARMA HOLDING AB EQUITY is traded ex capital adjustment on 17.09.2024...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Weil ich auf die Kraft der Wahrheit und des Geistes vertraue, glaube ich an die Zukunft der Menschheit. - Albert Schweitzer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram